Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Milan Pfizer |
---|---|
Information provided by: | University of Milan |
ClinicalTrials.gov Identifier: | NCT00323986 |
Aims of the study
Condition | Intervention | Phase |
---|---|---|
COPD Tracheostomy |
Drug: azithromycin (drug) |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy. Effects on Recurrent Respiratory Infections, Inflammatory Parameters and Bacterial Persistence |
Estimated Enrollment: | 30 |
Study Start Date: | October 2004 |
Estimated Study Completion Date: | April 2006 |
Ages Eligible for Study: | 45 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Italy | |
Istituto Nazionale di riposo e cura per anziani (INRCA) | |
Casatenovo, Italy, 23880 | |
Istituto Malattie Respiratorie University of Milan | |
Milan, Italy, 20122 | |
University Hospital Trieste | |
trieste, Italy, 34100 |
Principal Investigator: | Francesco Blasi, MD | Istituto Malattie Respiratorie University of Milan Italy |
Study ID Numbers: | 39/2004 |
Study First Received: | May 8, 2006 |
Last Updated: | May 8, 2006 |
ClinicalTrials.gov Identifier: | NCT00323986 |
Health Authority: | Italy: Ministry of Health |
COPD tracheotomy azithromycin |
exacerbation hospitalisation exhaled breath condensate |
Lung Diseases, Obstructive Respiratory Tract Diseases Respiratory Tract Infections Azithromycin |
Lung Diseases Recurrence Pulmonary Disease, Chronic Obstructive |
Anti-Infective Agents Anti-Bacterial Agents Therapeutic Uses Pharmacologic Actions |